Manufacturer copay assistance · Sandostatin LAR (J2353) · Novartis
$10-$25 per 30-day… · Maximum benefit $30,000 per calendar year (Novartis pays up to $10,630 per 30-day supply) · Covers drug cost only — administration billed separately
Published terms from the manufacturer. Per-patient eligibility is confirmed at enrollment.
This manufacturer program excludes government insurance. Foundation disease funds are the route instead — status shown as of each fund's last verification.
Run a benefits estimate for Sandostatin LAR — the program's cap applies against the patient share CareCost calculates.
Yes — Novartis Oncology Universal Co-pay Program from Novartis. $10-$25 per 30-day supply (varies by brand). Commercial insurance is required; Medicare and Medicaid patients are not eligible.
$10-$25 per 30-day supply (varies by brand) Maximum benefit: $30,000 per calendar year (Novartis pays up to $10,630 per 30-day supply). Covers drug cost only — administration billed separately
Accepted insurance: commercial. Not eligible: medicare, medicaid, government.